CatalystPit
TerminalPit ConsensusInsidersPoliticiansInstitutionsNewsScreener

AXSMAxsome Therapeutics, Inc.

NASDAQ · PHARMACEUTICAL PREPARATIONS
Last close $184.39 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryPHARMACEUTICAL PREPARATIONS
Market cap$9.66B
CountryUSA
RECENT INSIDER TRADES
  • 2026-09-03 · Jacobson Mark L. (Chief Operating Officer) · OTHER
  • 2026-09-03 · Jacobson Mark L. (Chief Operating Officer) · SELL
  • 2026-08-07 · TABUTEAU HERRIOT (Chief Executive Officer) · SELL
  • 2026-08-07 · TABUTEAU HERRIOT (Chief Executive Officer) · OTHER
INSTITUTIONAL OWNERSHIP
Institutional holders542
Shares held47,084,680
Value$10.26B
Percent of shares outstanding89.89%
As of quarter end2026-06-30
RECENT NEWS
  • Axsome Therapeutics to report Q3 2026 results Nov. 2
  • Axsome Therapeutics options flow shows heavy put skew ahead of binary catalyst
  • Axsome Therapeutics Announces Results of the Shared Goals Survey of Caregivers of Patients with Alzheimer’s Disease Agitation Presented at Psych Congress 2026 in Connection with World Alzheimer’s Day
  • Axsome Therapeutics Highlights Auvelity Growth, Pipeline Progress at H.C. Wainwright Conference
  • Analysts Think Axsome Therapeutics Stock Could Soar 35% Over the Next 12 Months. Is the Stock a No-Brainer Buy?
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS